Consolidated Statement of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating activities:
Amortization and write off of deferred financing costs	$ 1,628	$ 1,482
Cash provided by operating activities	36,323	30,295
Investing activities:
Capital expenditures	(27,269)	(25,519)
Proceeds from sale of royalty interests in oil properties	2,949
Proceeds from sale of equipment	129	64
Proceeds from maturities of certificates of deposit	245	1,000
Proceeds from sale of business		8,000
Cash used in investing activities	(23,946)	(16,455)
Financing activities:
Payments of bank debt	(34,713)	(27,280)
Bank borrowings	18,250	19,000
Deferred financing costs	(1,183)	(730)
Proceeds from noncontrolling interests (Note 13)		4,000
Taxes paid on vesting of RSUs	(14)	(11)
Dividends	(3,724)	(3,707)
Cash used in financing activities	(21,384)	(8,728)
Increase (decrease) in cash ,cash equivalents, and restricted cash	(9,007)	5,112
Cash, cash equivalents, and restricted cash beginning of year	20,094	16,294
Cash, cash equivalents, and restricted cash end of year	11,087	21,406
Cash, cash equivalents, and restricted cash consists of the following:
Cash, cash equivalents, and restricted cash, Total	20,094	16,294
Supplemental cash flow information:
Capital expenditures included in accounts payable, net	2,018	$ (8,957)
Right-to-use asset due to adoption of ASU 2016-02	$ 882